There have been updates in the scientific understanding of cervical cancer since the prior set of cervical cancer prevention and screening guidelines was published by the Hong Kong College of Obstetricians and Gynaecologists (HKCOG) in 2016, including novel nomenclature developed by the World Health Organization (WHO). New technologies such as 9-valent vaccines offer wider coverage against human papillomavirus (HPV) infections that lead to cervical cancer with added coverage implemented by population-based vaccination programs like the Hong Kong Childhood Immunisation Programme (HKCIP). Additionally, it was reminded that HPV tests need to be clinically validated and target high-risk strains including HPV16 and HPV18 to be effective for screening and triaging.

The Hong Kong College of Obstetricians and  Gynaecologists (HKCOG) has recently updated its guidelines on the prevention and screening of cervical cancer. The latest recommendations incorporated recent evidence on the role of co-testing with human papillomavirus (HPV)-based screening and cytology-based screening. In an interview with Omnihealth Practice, Dr. Wong, Ching-Yin Grace shared the rationale behind co-testing as the preferred testing modality in  The Family Planning Association of Hong Kong as it offers concurrent triaging. The combination of sensitivity with HPV tests and the specificity with cytology tests allows for a more lenient screening schedule for women in Hong Kong without compromising the benefit of cervical cancer detection.

The 2024 guidelines developed by the Hong Kong College of Obstetricians and Gynaecologists (HKCOG) respond to the pressing public health challenge of hepatitis B virus (HBV) infection, which affects approximately 296 million people worldwide and is responsible for around 820,000 deaths each year, primarily from cirrhosis and hepatocellular carcinoma.

With the median age of women having their first child in Hong Kong (HK) rising from 28.1 years in 1991 to 32.3 years in 2020, the rates of comorbidities and obstetric complications are expected to increase. Thus, notably, there is an increasing need for maternal critical care, resulting in the first HK maternal special care (MSC) unit being piloted in the Prince of Wales Hospital in May 2018 which aims to reduce maternal morbidity and mortality. In an interview with Omnihealth Practice, Dr. Hui, Shuk-Yi Annie talked about her experience in founding the first MSC unit in HK and shared a clinical case of preeclampsia with postpartum hemorrhage which benefited from the MSC unit and resolved without developing complications